Yoshimasa Hamano Selected Research

tocilizumab (atlizumab)

3/2013	Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab.
12/2011	A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment.
1/2009	Masked early symptoms of pneumonia in patients with rheumatoid arthritis during tocilizumab treatment: a report of two cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshimasa Hamano Research Topics

Disease

3	Rheumatoid Arthritis 03/2013 - 01/2009
2	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2017
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2017
2	Idiopathic Interstitial Pneumonias 01/2022 - 01/2017
2	Infections 12/2011 - 01/2009
1	Sarcoidosis (Schaumann Disease) 01/2017
1	Virus Diseases (Viral Diseases) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Pulmonary Alveolar Proteinosis 01/2017
1	Arthritis (Polyarthritis) 03/2013
1	Pain (Aches) 03/2013
1	Pneumonia (Pneumonitis) 01/2009

Drug/Important Bio-Agent (IBA)

3	tocilizumab (atlizumab)FDA Link 03/2013 - 01/2009
2	AutoantibodiesIBA 01/2022 - 01/2017
1	Immunoglobulin A (IgA)IBA 01/2022
1	InterferonsIBA 01/2017
1	SteroidsIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017

Therapy/Procedure

1	Therapeutics 12/2011